Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Circulating T-regulatory cells in PNET: a prospective study.

Tilak TV, Sharawat S, Gupta R, Agarwala S, Vishnubhatla S, Bakhshi S.

Pediatr Blood Cancer. 2014 Feb;61(2):228-32. doi: 10.1002/pbc.24734. Epub 2013 Aug 29.

PMID:
23997029
2.

Circulating T-regulatory cells in neuroblastoma: a pilot prospective study.

Tilak T, Sherawat S, Agarwala S, Gupta R, Vishnubhatla S, Bakhshi S.

Pediatr Hematol Oncol. 2014 Nov;31(8):717-22. doi: 10.3109/08880018.2014.886002. Epub 2014 Mar 31.

PMID:
24684178
3.

Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.

Biswas B, Agarwala S, Shukla NK, Deo S, Sharma D, Thulkar S, Vishnubhatla S, Bakhshi S.

Ann Thorac Surg. 2013 Dec;96(6):2006-14. doi: 10.1016/j.athoracsur.2013.06.062. Epub 2013 Sep 12.

PMID:
24035307
4.

Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.

Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.

Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.

PMID:
22495453
5.

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.

Głowala-Kosińska M, Chwieduk A, Nieckula J, Saduś-Wojciechowska M, Grosicki S, Rusin A, Nowara E, Giebel S.

Eur J Haematol. 2013 Aug;91(2):122-8. doi: 10.1111/ejh.12144. Epub 2013 Jun 15.

PMID:
23679234
6.

Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.

Bremm M, Huenecke S, Lehrnbecher T, Ponstingl E, Mueller R, Heinze A, Bug G, Quaiser A, Kapinsky M, Brehm C, Bader P, Schneider G, Klingebiel T, Koehl U.

J Immunol Methods. 2011 Oct 28;373(1-2):36-44. doi: 10.1016/j.jim.2011.07.018. Epub 2011 Aug 3.

PMID:
21839739
7.

Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.

Friedrich C, Warmuth-Metz M, von Bueren AO, Nowak J, Bison B, von Hoff K, Pietsch T, Kortmann RD, Rutkowski S.

J Neurosurg Pediatr. 2015 Mar;15(3):227-35. doi: 10.3171/2014.9.PEDS14213. Epub 2015 Jan 2.

PMID:
25555122
8.

Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.

McLean TW, Hertel C, Young ML, Marcus K, Schizer MA, Gebhardt M, Weinstein HJ, Perez-Atayde A, Grier HE.

J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):486-93.

PMID:
10598659
9.

Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.

Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D.

Inflamm Bowel Dis. 2011 Jan;17(1):160-70. doi: 10.1002/ibd.21308.

PMID:
20848510
11.

High burden of metastases and poor outcome in pelvic PNET.

Biswas B, Agarwala S, Rastogi S, Khan SA, Mohanti BK, Sharma DN, Pathy S, Bakhshi S.

Pediatr Blood Cancer. 2013 Sep;60(9):E97-9. doi: 10.1002/pbc.24552. Epub 2013 Apr 26.

PMID:
23625700
12.

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ.

Liver Transpl. 2006 Feb;12(2):277-84.

13.

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

Oberlin O, Rey A, Desfachelles AS, Philip T, Plantaz D, Schmitt C, Plouvier E, Lejars O, Rubie H, Terrier P, Michon J; Société Française des Cancers de l'Enfant.

J Clin Oncol. 2006 Aug 20;24(24):3997-4002.

PMID:
16921053
14.

Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.

PMID:
15236877
15.

Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.

Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, Vishnubhatla S, Ghose S, Bakhshi S.

Ophthalmology. 2012 Jul;119(7):1470-7. doi: 10.1016/j.ophtha.2012.01.029. Epub 2012 Mar 28.

PMID:
22463820
16.

The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.

Choi HS, Ha SY, Kim HM, Ahn SM, Kang MS, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kang ES.

Oncotarget. 2016 Feb 16;7(7):7940-51. doi: 10.18632/oncotarget.6958.

17.

Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.

Rech AJ, Mick R, Kaplan DE, Chang KM, Domchek SM, Vonderheide RH.

Cancer Immunol Immunother. 2010 Apr;59(4):599-607. doi: 10.1007/s00262-009-0780-x. Epub 2009 Oct 24.

PMID:
19855964
18.

[Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].

Li SP, Peng QQ, Ding T, Xu J, Zhang CQ, Feng KT, Li JQ.

Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):523-7. Chinese.

PMID:
19062720
19.

Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.

Yin M, Zhang J, Wang Y, Wang S, Böckler D, Duan Z, Xin S.

Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1825-31. doi: 10.1161/ATVBAHA.109.200303. Epub 2010 May 6.

20.

Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.

Lin SZ, Chen KJ, Xu ZY, Chen H, Zhou L, Xie HY, Zheng SS.

Cancer Prev Res (Phila). 2013 Jun;6(6):594-602. doi: 10.1158/1940-6207.CAPR-12-0379. Epub 2013 Apr 18.

Supplemental Content

Support Center